Subacute myoclonic measles encephalitis - An opportunistic HIV-associated infection.

HIV children and adolescents measles encephalitis myoclonus opportunistic infection (OI)

Journal

Frontiers in cellular neuroscience
ISSN: 1662-5102
Titre abrégé: Front Cell Neurosci
Pays: Switzerland
ID NLM: 101477935

Informations de publication

Date de publication:
2023
Historique:
received: 01 12 2022
accepted: 13 03 2023
medline: 21 4 2023
pubmed: 21 4 2023
entrez: 21 04 2023
Statut: epublish

Résumé

An unusual cluster of myoclonic epilepsy was observed in a Romanian pediatric HIV cohort concurrent with measles outbreaks. We describe this particular form of subacute measles encephalitis (SME) in a group of HIV-infected children and adolescents with severe immunosuppression. This is a single-center study, starting in 1997 and covering 4 measles outbreaks in Romania. The presumptive diagnosis of subacute myoclonic measles encephalitis (SMME) was based on: (1) epidemiological data, previous measles episode or presumed contact with measles virus (MV), (2) clinical presentation with initial localized myoclonic jerks with rapid extension and subsequent motor deficit with preserved mental status, and (3) neuroimaging studies revealing cortical gray matter lesions. Definitive diagnosis was based on a neuropathological exam and immunohistochemistry of brain tissues, and measles RNA detection in the cerebrospinal fluid (CSF). Thirty-six patients were diagnosed with a particular form of SME during consecutive measles outbreaks in Romania: 1996-1998 (22); 2005-2008 (12); 2010-2011 (1) and 2016-2018 (1). Most children were born in the late 80s and had parenterally acquired HIV infection in early childhood. Before the episode of SMME, 11 patients had confirmed measles, while the rest, without typical rash, had a respiratory tract infection and/or presumed previous measles contact. In all patients, the clinical onset was sudden, with unilateral myoclonus. MRI findings revealed mainly focal cortical gray matter lesions. Neurologic symptoms progressed rapidly to coma and death in most patients. Three patients survived SMME, they had higher CD4 count at onset, slower progression of neurological symptoms, and benefit of immune recovery with cART. Immunocytochemistry studies revealed MV in the brain with a pattern suggesting an ascending viral neural infection. MV was isolated from CSF in 7 out of 8 patients. Sequence analysis of MV RNA from both nasopharyngeal swabs and CSF was available for one patient with similar N-450 strain characteristics. During an outbreak of measles, neurological manifestations, especially myoclonus in immunosuppressed patients, can be related to measles even in the absence of an acute episode. This particular form of subacute myoclonic measles encephalitis is an opportunistic fatal disease. Immune recovery due to effective antiretroviral treatment might increase survival.

Identifiants

pubmed: 37082207
doi: 10.3389/fncel.2023.1113935
pmc: PMC10110848
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1113935

Subventions

Organisme : NIMH NIH HHS
ID : P30 MH062512
Pays : United States

Informations de copyright

Copyright © 2023 Ene, Duiculescu, Radoi, Lazar, Tardei, Ungureanu, Ruta, Vinters, Letendre, Grant, Ellis and Achim.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Euro Surveill. 2019 Jul;24(29):
pubmed: 31339098
Front Public Health. 2019 Apr 25;7:98
pubmed: 31073518
J Med Virol. 2007 Sep;79(9):1381-7
pubmed: 17607778
Front Neurol. 2020 Nov 23;11:585527
pubmed: 33329331
Clin Infect Dis. 1993 May;16(5):654-60
pubmed: 8323578
J Infect Dis. 1988 Aug;158(2):480-3
pubmed: 3403997
Acta Cytol. 1998 May-Jun;42(3):729-33
pubmed: 9622696
Euro Surveill. 2013 Dec 12;18(50):20658
pubmed: 24342518
J Virol. 2019 Apr 3;93(8):
pubmed: 30728259
Lancet. 2009 Jan 31;373(9661):383-9
pubmed: 19131097
Clin Med Res. 2016 Dec;14(3-4):156-158
pubmed: 27777245
J Med Virol. 1978;2(4):305-17
pubmed: 731212
Emerg Infect Dis. 2020 Sep;26(9):2231-2234
pubmed: 32818389
Arch Neurol. 2012 Dec;69(12):1644-7
pubmed: 22944871
Ann Neurol. 1977 May;1(5):452-7
pubmed: 214019
Clin Neurol Neurosurg. 2010 Sep;112(7):572-4
pubmed: 20427123
Risk Anal. 2017 Jun;37(6):1096-1107
pubmed: 27439071
J Neurol Sci. 1982 Jan;53(1):29-43
pubmed: 7035621
Acta Microbiol Immunol Hung. 2018 Jun 1;65(2):127-134
pubmed: 29486573
Schweiz Arch Neurol Psychiatr (1985). 1986;137(1):47-55
pubmed: 2419998
J Infect Dis. 2005 Jul 1;192(1):71-8
pubmed: 15942896
Acta Paediatr. 2004 Sep;93(9):1251-3
pubmed: 15384893
BMJ Case Rep. 2021 Sep 13;14(9):
pubmed: 34518172
Clin Infect Dis. 1999 Jul;29(1):106-12
pubmed: 10433572
Cureus. 2017 Jun 13;9(6):e1346
pubmed: 28713662
Sci Adv. 2023 Jan 27;9(4):eadf3731
pubmed: 36706187
Braz J Infect Dis. 2003 Oct;7(5):346-52
pubmed: 14552745
Lancet. 1967 Jul 15;2(7507):129-31
pubmed: 4165642
Mov Disord. 2003 Dec;18(12):1533-8
pubmed: 14673894
Acta Neuropathol. 1998 Dec;96(6):637-42
pubmed: 9845294
Rev Neurol. 2003 Aug 16-31;37(4):318-21
pubmed: 14533106
Mod Pathol. 1992 May;5(3):348-52
pubmed: 1353879
Neurol Sci. 2011 Dec;32(6):1007-12
pubmed: 21052755
J Virol Methods. 2005 Sep;128(1-2):79-87
pubmed: 15913798
HIV Med. 2006 Oct;7(7):467-70
pubmed: 16925733
Oxf Med Case Reports. 2016 Oct 01;2016(10):omw077
pubmed: 27699054
Ann Ist Super Sanita. 2017 Apr-Jun;53(2):167-169
pubmed: 28617265
Arq Neuropsiquiatr. 2002 Sep;60(3-A):525-30
pubmed: 12244384
Neurology. 1996 Feb;46(2):586-7
pubmed: 8614546
Pediatr Infect Dis J. 2009 Jan;28(1):63-5
pubmed: 19057456
J Neurovirol. 2018 Feb;24(1):123-127
pubmed: 29243132
J Clin Pathol. 1976 Oct;29(10):865-72
pubmed: 789401
Neurol India. 2017 Nov-Dec;65(6):1333-1344
pubmed: 29133711
J Infect Dis. 2012 Aug 15;206(4):512-22
pubmed: 22693229
Virol J. 2013 Sep 12;10:283
pubmed: 24025157
Euro Surveill. 2010 Oct 07;15(40):
pubmed: 20946758
Neurology. 1999 Mar 23;52(5):1074-7
pubmed: 10102434
S Afr Med J. 2011 May;101(5):313-4, 316-7
pubmed: 21837871
Bacteriol Virusol Parazitol Epidemiol. 2007 Jul-Dec;52(3-4):149-56
pubmed: 19326728
Dev Med Child Neurol. 1995 Dec;37(12):1117-9
pubmed: 8566472
Ann Epidemiol. 2000 Oct 1;10(7):474-475
pubmed: 11018412
Neurology. 1981 Oct;31(10):1263-70
pubmed: 7202137
Biomed Pharmacother. 1988;42(1):11-4
pubmed: 3044455
Neurol Clin. 1985 Feb;3(1):179-96
pubmed: 2581121
Am J Epidemiol. 1999 Dec 1;150(11):1250-7
pubmed: 10588086
J Clin Neurosci. 2002 Sep;9(5):600-4
pubmed: 12383429
Int J STD AIDS. 2017 Aug;28(9):937-939
pubmed: 28077023
J Infect Dis. 2003 May 15;187 Suppl 1:S217-22
pubmed: 12721916

Auteurs

Luminita Ene (L)

"Dr. Victor Babes" Hospital for Infectious and Tropical Diseases, Bucharest, Romania.

Dan Duiculescu (D)

"Dr. Victor Babes" Hospital for Infectious and Tropical Diseases, Bucharest, Romania.

Roxana Radoi (R)

"Dr. Victor Babes" Hospital for Infectious and Tropical Diseases, Bucharest, Romania.

Mihaela Lazar (M)

Cantacuzino Institute, Bucharest, Romania.

Gratiela Tardei (G)

"Dr. Victor Babes" Hospital for Infectious and Tropical Diseases, Bucharest, Romania.

Eugenia Ungureanu (E)

"Dr. Victor Babes" Hospital for Infectious and Tropical Diseases, Bucharest, Romania.

Simona Ruta (S)

Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.
Ştefan S. Nicolau Institute of Virology, Bucharest, Romania.

Harry V Vinters (HV)

University of California, Los Angeles, Los Angeles, CA, United States.

Scott Letendre (S)

University of California, San Diego, La Jolla, CA, United States.

Igor Grant (I)

University of California, San Diego, La Jolla, CA, United States.

Ronald J Ellis (RJ)

University of California, San Diego, La Jolla, CA, United States.

Cristian L Achim (CL)

University of California, San Diego, La Jolla, CA, United States.

Classifications MeSH